Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 58

    Zydus Cadila gets tentative USFDA nod for Lorcaserin Hydrochloride Tablets to treat obesity

    Zydus Cadila gets tentative USFDA nod for Lorcaserin Hydrochloride Tablets to treat obesity

    Farhat Nasim4 Dec 2019 9:30 AM IST
    Lorcaserin Hydrochloride Tablets will be manufactured at the group’s formulations manufacturing facility at $132, Zydus Cadila said in a filing.New...
    Indian-origin pharmacy technician held guilty of illegally distributing oxycodone pills

    Indian-origin pharmacy technician held guilty of illegally distributing oxycodone pills

    Medical Dialogues Bureau4 Dec 2019 9:20 AM IST
    Anmol Singh Kamra of Philadelphia, a pharmacy technician conspired with George Fisher, a physician, and Frank Brown, both charged separately, to...
    Astellas Pharma to buy Audentes Therapeutics for USD 2.7 billion

    Astellas Pharma to buy Audentes Therapeutics for USD 2.7 billion

    Medical Dialogues Bureau4 Dec 2019 9:15 AM IST
    Astellas Pharma offer of $60 per share represents a 110% premium to Audentes closing price on Monday.New Delhi: Japan’s Astellas Pharma Inc said on...
    DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

    DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

    Farhat Nasim3 Dec 2019 1:06 PM IST
    New Delhi: Communicating to all manufacturers about the Centre for Development for Advanced Computing (CDAC) guidelines for uploading various...
    Cadila Healthcare to merge with 4 subsidiaries to cut costs, overheads

    Cadila Healthcare to merge with 4 subsidiaries to cut costs, overheads

    Farhat Nasim3 Dec 2019 11:44 AM IST
    "The amalgamation is being done for consolidation of pharmaceutical business and merger simplification of corporate structure to avoid duplication of...
    Biocon, Mylan unveil biosimilar Ogivri to treat breast, gastric cancer in US

    Biocon, Mylan unveil biosimilar Ogivri to treat breast, gastric cancer in US

    Farhat Nasim3 Dec 2019 11:30 AM IST
    Ogivri is available in a 420 mg multi-dose vial and a 150 mg single-dose vial in order to provide the patients dosing and treatment flexibility,...
    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

    Farhat Nasim3 Dec 2019 9:50 AM IST
    Siddharth Mittal takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on November 30,...
    Sanofi to sell surgical unit Seprafilm to Baxter for USD 350 million: Report

    Sanofi to sell surgical unit Seprafilm to Baxter for USD 350 million: Report

    Farhat Nasim3 Dec 2019 9:45 AM IST
    Sanofi took on Seprafilm, which is used to help manage the bleeding in abdominal and the pelvis operations, in 2011 as part of its purchase of...
    Recipharm plans to launch RedHill helicobacter pylori infection drug Talicia in Q1 2020

    Recipharm plans to launch RedHill helicobacter pylori infection drug Talicia in Q1 2020

    Medical Dialogues Bureau3 Dec 2019 9:15 AM IST
    New Delhi: Recipharm, the contract development and manufacturing organisation (CDMO), announced recently ongoing large-scale commercial manufacturing...
    Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

    Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

    Farhat Nasim2 Dec 2019 3:43 PM IST
    The approved ANDA(Diclofenac Sodium Topical Solution) is therapeutically equivalent to the reference listed drug product (RLD), Pennsaid Topical...
    Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

    Jubilant Life Sciences arm expands drug discovery services biz in Greater Noida, Bengaluru

    Medical Dialogues Bureau2 Dec 2019 3:35 PM IST
    Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys(Bengaluru-based subsidiary of...
    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Farhat Nasim2 Dec 2019 11:28 AM IST
    On November 27, 2019, the US District Court (District of Massachusetts) entered a decision denying in part and granting in part Sun Pharma Ltd’s...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok